195 related articles for article (PubMed ID: 25138808)
21. Change in glomerular filtration rate over time in the Oxford Renal Cohort Study: observational study.
Hirst JA; Taal MW; Fraser SD; Mena JMO; O'Callaghan CA; McManus RJ; Taylor CJ; Yang Y; Ogburn E; Hobbs FR
Br J Gen Pract; 2022 Apr; 72(717):e261-e268. PubMed ID: 34990394
[TBL] [Abstract][Full Text] [Related]
22. Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD.
Wan EYF; Yu EYT; Chan L; Mok AHY; Wang Y; Chan EWY; Wong ICK; Lam CLK
Clin J Am Soc Nephrol; 2021 Jun; 16(6):898-907. PubMed ID: 33910887
[TBL] [Abstract][Full Text] [Related]
23. The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function.
Murray AM; Bell EJ; Tupper DE; Davey CS; Pederson SL; Amiot EM; Miley KM; McPherson L; Heubner BM; Gilbertson DT; Foley RN; Drawz PE; Slinin Y; Rossom RC; Lakshminarayan K; Vemuri P; Jack CR; Knopman DS
Am J Kidney Dis; 2016 Apr; 67(4):593-600. PubMed ID: 26744128
[TBL] [Abstract][Full Text] [Related]
24. Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.
Jordan F; Quinn TJ; McGuinness B; Passmore P; Kelly JP; Tudur Smith C; Murphy K; Devane D
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD011459. PubMed ID: 32352165
[TBL] [Abstract][Full Text] [Related]
25. NSAID use and progression of chronic kidney disease.
Gooch K; Culleton BF; Manns BJ; Zhang J; Alfonso H; Tonelli M; Frank C; Klarenbach S; Hemmelgarn BR
Am J Med; 2007 Mar; 120(3):280.e1-7. PubMed ID: 17349452
[TBL] [Abstract][Full Text] [Related]
26. Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study.
Abd ElHafeez S; Hegazy R; Naga Y; Wahdan I; Sallam S
J Egypt Public Health Assoc; 2019; 94(1):8. PubMed ID: 30799879
[TBL] [Abstract][Full Text] [Related]
27. Chronic pain and analgesic use in CKD: implications for patient safety.
Wu J; Ginsberg JS; Zhan M; Diamantidis CJ; Chen J; Woods C; Fink JC
Clin J Am Soc Nephrol; 2015 Mar; 10(3):435-42. PubMed ID: 25710806
[TBL] [Abstract][Full Text] [Related]
28. Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector.
Meuwesen WP; du Plessis JM; Burger JR; Lubbe MS; Cockeran M
Int J Clin Pharm; 2016 Aug; 38(4):863-9. PubMed ID: 27091130
[TBL] [Abstract][Full Text] [Related]
29. Opioid-sparing effects of perioperative paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) in children.
Wong I; St John-Green C; Walker SM
Paediatr Anaesth; 2013 Jun; 23(6):475-95. PubMed ID: 23570544
[TBL] [Abstract][Full Text] [Related]
30. Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease.
Patel K; Diamantidis C; Zhan M; Hsu VD; Walker LD; Gardner J; Weir MR; Fink JC
Am J Nephrol; 2012; 36(1):19-26. PubMed ID: 22699456
[TBL] [Abstract][Full Text] [Related]
31. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239
[TBL] [Abstract][Full Text] [Related]
32. Association of functional and structural social support with chronic kidney disease among African Americans: the Jackson Heart Study.
Hall RK; Davenport CA; Sims M; Colón-Emeric C; Washington T; St Clair Russell J; Pendergast J; Bhavsar N; Scialla J; Tyson CC; Wang W; Min YI; Young B; Boulware LE; Diamantidis CJ
BMC Nephrol; 2019 Jul; 20(1):262. PubMed ID: 31307430
[TBL] [Abstract][Full Text] [Related]
33. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?
Barozzi N; Tett SE
Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1184-91. PubMed ID: 17636557
[TBL] [Abstract][Full Text] [Related]
34. Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.
Guessous I; McClellan W; Kleinbaum D; Vaccarino V; Hugues H; Boulat O; Marques-Vidal P; Paccaud F; Theler JM; Gaspoz JM; Burnier M; Waeber G; Vollenweider P; Bochud M
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1162-9. PubMed ID: 25901090
[TBL] [Abstract][Full Text] [Related]
35. Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease.
Pastori D; Pignatelli P; Perticone F; Sciacqua A; Carnevale R; Farcomeni A; Basili S; Corazza GR; Davì G; Lip GYH; Violi F;
Int J Cardiol; 2016 Nov; 223():619-624. PubMed ID: 27565838
[TBL] [Abstract][Full Text] [Related]
36. Management of patients with chronic kidney disease: a French medical centre database analysis.
Ariza M; Martin S; Dusenne M; Darmon D; Schuers M
Fam Pract; 2024 Jun; 41(3):262-269. PubMed ID: 36708191
[TBL] [Abstract][Full Text] [Related]
37. Use of paracetamol, low-dose aspirin, or non-aspirin non-steroidal anti-inflammatory drugs and risk of ovarian borderline tumors in Denmark.
Hannibal CG; Dehlendorff C; Kjaer SK
Gynecol Oncol; 2018 Dec; 151(3):513-518. PubMed ID: 30249529
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of chronic kidney disease in Australian general practice: National Prescribing Service MedicineWise MedicineInsight dataset.
Radford J; Kitsos A; Stankovich J; Castelino R; Khanam M; Jose M; Peterson G; Saunder T; Wimmer B; Razizaidi T
Nephrology (Carlton); 2019 Oct; 24(10):1017-1025. PubMed ID: 30467996
[TBL] [Abstract][Full Text] [Related]
39. White blood cell count predicts the odds of kidney function decline in a Chinese community-based population.
Fan F; Jia J; Li J; Huo Y; Zhang Y
BMC Nephrol; 2017 Jun; 18(1):190. PubMed ID: 28592280
[TBL] [Abstract][Full Text] [Related]
40. Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer.
García Rodríguez LA; González-Pérez A
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):649-53. PubMed ID: 15066932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
